Ticker Symbol: KALTF

Claritas Pharmaceuticals Inc

Exchange: US OTC Country: US Currency: USD Asset Type: Common Stock CIK:0001639643

Company Profile

Kalytera Therapeutics, Inc. engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bon fracture healing; osteogenesis imperfecta; osteoporosis; and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in San Rafael, CA.

Sector: Health Technology

Industry: Pharmaceuticals: Other

Standard Industrial Classification Code (SIC code): 2833

Address: 4040 Civic Center Drive

Website: http://www.kalytera.co

CEO: Robert Edward Farrell

Tags:

Pharmaceuticals: Other
Health Technology

Pricing

Last Updated: January 28, 2022 04:00 PM EST

Previous Close: $0.13

Change: $0.01 ( 15.83%)

Days Range: $0.13 - $0.13

Beta: -

52wk. High: $0.70

52wk. Low: $0.00

Ytd. Change -4.80%

50 Day Moving Average: $0.15

200 Day Moving Average: $0.19

Shares Outstanding: 36705504

Valuation

Market Cap: 510.2M

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A